Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
A Randomized, Double‐Blind, Placebo‐Controlled, Three‐Arm, Parallel‐Design, Multiple‐Site Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel 3% (Encube Ethicals) Compared to Solaraze® (diclofenac sodium) Gel 3% (Fougera Pharmaceuticals Inc.) in the Treatment of Actinic Keratosis
Epistemonikos ID: 72693bbe67a3ba4d6fc9e01605186976dd477a01
First added on: May 22, 2024